Perioperative risk after urgent surgery following type 2 NSTEMI
Urgent noncardiac surgery soon after a recent NSTEMI is associated with higher 30-day major adverse cardiovascular and cerebrovascular event (MACCE) risk than surgery without a recent NSTEMI, based on Medicare data in older adults. [1] Published evidence specifically stratifying risk by MI subtype (type 2 vs type 1) before surgery is limited, so risk estimates are most defensible when applied to “recent NSTEMI/MI” rather than exclusively to type 2 NSTEMI. [1]
Best available risk estimates after recent NSTEMI (not subtype-specific)
In Medicare patients undergoing elective and nonelective major noncardiac surgery, NSTEMI within 30 days was associated with increased odds of MACCE at 30 days versus no prior NSTEMI. [1]
- For NSTEMI within 30 days, adjusted odds ratio for MACCE was 2.15 (95% CI 1.09-4.23) in the cohort that includes both revascularized and nonrevascularized patients. [1]
- The association persisted when stratified by coronary revascularization status, with adjusted odds ratios of 2.04 (95% CI 1.31-3.16) for patients without coronary revascularization and 2.15 (95% CI 1.09-4.23) overall. [1]
Mechanistic and clinical interpretation of “type 2 NSTEMI” in perioperative risk
Type 2 NSTEMI reflects myocardial oxygen supply–demand mismatch rather than a coronary plaque rupture mechanism. [1] Perioperative risk after type 2 NSTEMI therefore depends heavily on the precipitating systemic condition (for example, sepsis, hypoxemia, anemia, arrhythmia) and on residual coronary disease severity. [1] However, Medicare-based perioperative risk estimates do not separate MI mechanism as type 2 versus type 1, so the reported MACCE risk is not specific to type 2 NSTEMI. [1]
Urgency of surgery and short-interval risk
In observational perioperative datasets, overall 30-day mortality after prior cardiovascular events is higher for emergency surgery than for elective surgery. [2] The study reporting this urgency effect evaluates prior cardiovascular events broadly and does not provide a type 2 NSTEMI–specific estimate. [2]
Clinical decision framework for proceeding when surgery cannot be deferred
A perioperative cardiovascular management assessment is recommended using multidisciplinary, shared decision-making to balance bleeding risk, thrombotic risk, and consequences of delaying surgery. [3] Evaluation of recent ischemic events uses guideline-consistent clinical risk assessment tools and perioperative surveillance strategies, with additional attention to active or unstable coronary disease features. [3]
Data limitations relevant to “type 2 NSTEMI”
No high-quality perioperative study was identified that provides a separate 30-day event rate (mortality, MI, stroke, MACCE) for type 2 NSTEMI versus type 1 NSTEMI at the time of urgent surgery. [1] Therefore, the only quantitatively supported short-interval risk estimate applicable to the question is derived from perioperative studies using NSTEMI/MI diagnosis coding without type 2 mechanistic adjudication. [1]
Practical risk numbers for counseling (best-supported interval)
The most directly applicable quantified risk signal is increased odds of MACCE when NSTEMI occurred within 30 days before surgery. [1]
- Adjusted odds ratio for MACCE at 30 days after surgery: 2.15 (95% CI 1.09-4.23) for NSTEMI within 30 days. [1]
Targets for risk communication (what to document)
Recent MI timing should be documented as “≤30 days since NSTEMI/MI” because this interval carries the strongest association with perioperative MACCE. [1] MI mechanism should be documented as type 2 in the clinical record when diagnosed, but perioperative risk estimates should still be labeled as not subtype-specific. [1] Urgency (elective versus nonelective/emergency) should be documented because urgency modifies perioperative mortality risk in observational cohorts. [2]
References
[1] Medicare-based study: time since prior NSTEMI and MACCE after noncardiac surgery. [1] [2] JAMA Surgery study: 30-day mortality by urgency after prior cardiovascular events. [2] [3] 2024 AHA/ACC perioperative cardiovascular management guideline: multidisciplinary decision-making for timing and perioperative risk balancing. [3]